Akut limfoid leukémia (ALL): vizsgálatok itt: Szingapúr
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Singapore
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 3. fázisTaking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Singapore
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Singapore
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - 2. fázisTaking peopleMa-Spore ALL 2020 Study
- Where
- Singapore
- Életkor
- Up to 40 év
- People
- 500 worldwide
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06336395 - 2. fázisTaking peopleCD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
- Where
- Singapore
- Életkor
- 0 év to 70 év
- People
- 40
- Run by
- KK Women's and Children's Hospital
See details and how to joinNCT05648019